Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Report 2017

Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Report 2017

1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overview

1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

1.2 Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

1.2.1 Preface

1.2.2 Eluxadoline

1.2.3 Alosetron

1.2.4 Rifaximin

1.2.5 Loperamide

1.2.6 Diphenoxylate + Atropine

1.2.7 Dicyclomine and Hyoscyamine

1.3 Application of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Others

1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2012-2022)

1.5.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2022)

1.5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Manufacturers, Type and Application

2.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competition by Manufacturers

2.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume and Value) by Type

2.2.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)

2.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume and Value) by Countries

2.3.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Countries (2012-2017)

2.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume) by Application

3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

3.1 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

3.1.1 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

3.1.2 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

3.1.3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

3.2 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

3.3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

3.4 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

4.1 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

4.1.1 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

4.1.2 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

4.1.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

4.2 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

4.3 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

4.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

5 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

5.1 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

5.1.1 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

5.1.2 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

5.1.5 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

5.2 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

5.3 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

5.4 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

6 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

6.1 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

6.1.1 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

6.1.2 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

6.1.6 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

6.2 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

6.3 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

6.4 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

7 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

7.1 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

7.1.1 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

7.1.2 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

7.1.7 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

7.2 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

7.3 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

7.4 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

8 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

8.1 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

8.1.1 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

8.1.2 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

8.1.8 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

8.2 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

8.3 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

8.4 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

9 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (Volume, Value and Sales Price)

9.1 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Value (2012-2017)

9.1.1 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

9.1.2 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

9.2 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturers

9.3 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type

9.4 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application

10 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Analysis

10.1 Astellas Pharmaceuticals

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification

10.1.2.1 Preface

10.1.2.2 Eluxadoline

10.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Actavis

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification

10.2.2.1 Preface

10.2.2.2 Eluxadoline

10.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Pfizer

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification

10.3.2.1 Preface

10.3.2.2 Eluxadoline

10.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 GlaxoSmithKline

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification

10.4.2.1 Preface

10.4.2.2 Eluxadoline

10.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Salix Pharmaceuticals Ltd

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification

10.5.2.1 Preface

10.5.2.2 Eluxadoline

10.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 AstraZenenca

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type, Application and Specification

10.6.2.1 Preface

10.6.2.2 Eluxadoline

10.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

11 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Cost Analysis

11.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2017-2022)

14.1 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.2 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.3 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.4 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.5 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.6 Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.7 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast (2017-2022)

14.8 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2017-2022)

14.9 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Table Classification of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure Europe Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2015

Figure Preface Picture

Figure Eluxadoline Picture

Figure Alosetron Picture

Figure Rifaximin Picture

Figure Loperamide Picture

Figure Diphenoxylate + Atropine Picture

Figure Dicyclomine and Hyoscyamine Picture

Table Application of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure Europe Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure Others Examples

Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2022)

Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2022)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers

Figure 2016 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers

Table 2016 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)

Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Type (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2012-2017)

Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate by Type (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Countries (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Countries (2012-2017)

Figure Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Countries (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Application (2012-2017)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application (2012-2017)

Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Figure Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2012-2017)

Figure Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2012-2017)

Figure Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Price Trend (2012-2017)

Table Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015 and 2016)

Table Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type (2015 and 2016)

Table Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015 and 2016)

Table Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2015 and 2016)

Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information List

Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (2012-2017)

Table Actavis Basic Information List

Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (2012-2017)

Table Salix Pharmaceuticals Ltd Basic Information List

Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (2012-2017)

Table AstraZenenca Basic Information List

Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain Analysis

Table Raw Materials Sources of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Manufacturers in 2015

Table Major Buyers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Table Distributors/Traders List

Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Spain Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate Forecast (2017-2022)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2017-2022)

Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2017-2022)